Nynomic AG
XETRA:M7U
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.7
36.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Nynomic AG
Capital Expenditures
Nynomic AG
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Nynomic AG
XETRA:M7U
|
Capital Expenditures
-€9.2m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
||
Jenoptik AG
XETRA:JEN
|
Capital Expenditures
-€90.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
||
LPKF Laser & Electronics AG
XETRA:LPK
|
Capital Expenditures
-€6.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
||
Stemmer Imaging AG
XETRA:S9I
|
Capital Expenditures
-€464k
|
CAGR 3-Years
-30%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
||
Brockhaus Technologies AG
XETRA:BKHT
|
Capital Expenditures
-€3.7m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-154%
|
CAGR 10-Years
N/A
|
||
L
|
LPKF Laser & Electronics SE
XMUN:LPK
|
Capital Expenditures
-€6.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
Nynomic AG
Glance View
Nynomic AG engages in the manufacture of products for optical metrology. The company is headquartered in Wedel, Schleswig-Holstein and currently employs 428 full-time employees. The company went IPO on 2007-07-02. The company covers product conception, design, evaluation, development and market introduction, and operates through three segments: Clean Tech, Green Tech and Life Science. The Clean Tech segment offers sensors and measuring systems for industrial producers and system operates, such as bioplants; the Green Tech segment focuses on farming solutions, as well as the food and beverage industries, and offers solutions for harvest monitoring and animal feeding, and the Life Science segment focuses on medical technology, such as spectrometers, laboratory instruments and other analytical solutions.
See Also
What is Nynomic AG's Capital Expenditures?
Capital Expenditures
-9.2m
EUR
Based on the financial report for Jun 30, 2024, Nynomic AG's Capital Expenditures amounts to -9.2m EUR.
What is Nynomic AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-29%
Over the last year, the Capital Expenditures growth was -222%. The average annual Capital Expenditures growth rates for Nynomic AG have been -65% over the past three years , -29% over the past five years .